National Heart and Lung Institute, Imperial College London , London, UK.
J Exp Med. 2023 Jun 5;220(6). doi: 10.1084/jem.20221094. Epub 2023 May 10.
Allergic asthma is among the most common immune-mediated diseases across the world, and type 2 immune responses are thought to be central to pathogenesis. The importance of T helper 2 (Th2) cells as central regulators of type 2 responses in asthma has, however, become less clear with the discovery of other potent innate sources of type 2 cytokines and innate mediators of inflammation such as the alarmins. This review provides an update of our current understanding of Th2 cells in human asthma, highlighting their many guises and functions in asthma, both pathogenic and regulatory, and how these are influenced by the tissue location and disease stage and severity. It also explores how biologics targeting type 2 immune pathways are impacting asthma, and how these have the potential to reveal hitherto underappreciated roles for Th2 cell in lung inflammation.
过敏性哮喘是全球最常见的免疫介导疾病之一,人们认为 2 型免疫反应是发病机制的核心。然而,随着人们发现其他强效的 2 型细胞因子先天来源和先天炎症介质(如警报素),辅助性 T 细胞 2(Th2)细胞作为 2 型反应的中心调节剂的重要性已经变得不那么明显。这篇综述提供了我们目前对人类哮喘中 Th2 细胞的理解的最新更新,强调了它们在哮喘中的多种表现形式和功能,包括致病性和调节性,以及这些功能如何受到组织位置、疾病阶段和严重程度的影响。它还探讨了针对 2 型免疫途径的生物制剂如何影响哮喘,以及它们如何有可能揭示 Th2 细胞在肺部炎症中迄今未被充分认识的作用。